Achillion stock plunges as FDA maintains clinical hold on hep C drug

(Reuters) - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration decided not to lift a clinical hold it had placed on the firm's hepatitis C drug, sovaprevir, leaving an uncertain fate for the company's most promising d...

Source: http://health.yahoo.net/news/s/nm/achillion-stock-plunges-as-fda-maintains-clinical-hold-on-hep-c-drug

example here as example as an example explained here